论文部分内容阅读
近年来,大量的基础研究和临床实践已证实,支气管哮喘病人的支气管粘膜存在不同程度的过敏性炎症,导致支气管粘膜发生水肿、充血,大量肥大细胞和嗜酸性细胞浸润,引起广泛气道阻塞症状。因此,近年对支气管哮喘的防治取得可喜的新进展。现作简要介绍: 一、肾上腺糖皮质激素(以下称激素)的局部应用 现已明确支气管哮喘的本质是支气管慢性过敏性炎症,应使用抗过敏性炎症的药物来治疗。目前认为最理想的防治药物是β—氯地米松二丙酯(必可酮)气雾剂或其
In recent years, a large number of basic research and clinical practice have confirmed that bronchial mucosa of bronchial asthma patients have varying degrees of allergic inflammation, leading to bronchial mucosa edema, congestion, a large number of mast cells and eosinophil infiltration, causing extensive airway obstruction symptoms . Therefore, in recent years, the prevention and treatment of bronchial asthma made gratifying new progress. Now make a brief introduction: First, the adrenal glucocorticoid (hereinafter referred to as hormones) local application has been clear that the essence of bronchial asthma is bronchial chronic allergic inflammation, anti-allergic inflammation drugs should be used to treat. Currently considered the best anti-drug is β-beclometasone dipropyl (acetone) aerosol or its